Sam Chun Dang Pharm Co., Ltd. Insider Trading
000250.XKRX
Sam Chun Dang Pharm Co., Ltd.'s insiders don't report trades to the SEC
Insider trades on this page come from SEC Form 4 filings. 000250.XKRX is a company from outside the US, so its directors report their trades to the market regulator in its home country instead, and there are no Form 4 filings to show. This is the case for most companies listed outside the US, and for foreign companies with US-listed shares.
See what insiders are buying in US companies
Open-market buys by executives and directors, from today's SEC filings.
Held by ETFs
000250.XKRX is in 12 US ETFs. The largest of them, with 000250.XKRX's weight in each:
iShares Core MSCI Emerging Markets ETFIEMG0.02%of the fund
State Street SPDR Portfolio Developed World ex-US ETFSPDW0.02%of the fund
Vanguard FTSE All-World ex-US Small-Cap Index FundVSS0.05%of the fund
Vanguard FTSE Pacific ETFVPL0.01%of the fund
Schwab International Small-Cap Equity ETFSCHC0.08%of the fund
WisdomTree Emerging Markets ex-State-Owned Enterprises FundXSOE0.02%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing 000250.XKRX
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.